Construction of a pharmaceutical plant for the production of the original medicinal substance N-Pentoxenial and the original drug "Notaloron" for the treatment of liver diseases. The number of jobs created is 90.
Initiator of the Project:
Pharmaceutical company "Beisenpharm" LLP.
Marketable products and capacities:
The drug "Notaloron" – 6,160 thousand packages.
Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan, Mongolia, Turkey, Belarus, Russia.
- N-Pentoxenial: concentrate preparation filtration-hot packing-freezing and aging-labeling and packaging-storage in a warehouse.
- Notaloron: preparation of solution-preparation of ampoules-filling of ampoules with solution-control of ampoules with solution -packing of ampoules in a blister, in a pack storage in a warehouse of finished products.
The absence of similar productions. There is no production of injectable hepatoprotectors in Kazakhstan, the market niche is free.
Plans to expand indications for use. The initiator plans to further expand the indications for the use of the drug by conducting additional clinical studies (including children and pregnant women, as well as patients with non-alcoholic steatohepatitis in the indications for use). The expansion of indications for the use of the drug will increase the Company's sales market.
Plans to include the drug in the public procurement. In accordance with the legislation of the Republic of Kazakhstan, domestic suppliers have advantages in conducting state purchases of medicines. In case of selection of a domestic producer as a supplier, a Single distributor of SC Pharmacy LLP enters into a long-term supply contract with him for up to 10 years.